Clal Insurance’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-315,776
| Closed | -$35.3M | – | 114 |
|
|
2019
Q1 | $35.3M | Sell |
315,776
-422,758
| -57% | -$47.3M | 0.86% | 37 |
|
|
2018
Q4 | $71.2M | Hold |
738,534
| – | – | 1.85% | 17 |
|
|
2018
Q3 | $90.1M | Hold |
738,534
| – | – | 2.39% | 13 |
|
|
2018
Q2 | $81.2M | Hold |
738,534
| – | – | 2.11% | 13 |
|
|
2018
Q1 | $78.8M | Sell |
738,534
-1,169,091
| -61% | -$125M | 2.1% | 15 |
|
|
2017
Q4 | $204M | Hold |
1,907,625
| – | – | 5.36% | 4 |
|
|
2017
Q3 | $212M | Buy |
1,907,625
+1,215,273
| +176% | +$135M | 5.12% | 5 |
|
|
2017
Q2 | $71.6M | Buy |
692,352
+23,340
| +3% | +$2.41M | 1.42% | 16 |
|
|
2017
Q1 | $65.4M | Sell |
669,012
-29,088
| -4% | -$2.84M | 1.33% | 16 |
|
|
2016
Q4 | $61.8M | Buy |
698,100
+11,160
| +2% | +$987K | 1.16% | 16 |
|
|
2016
Q3 | $66.3M | Buy |
+686,940
| New | +$66.3M | 1.49% | 11 |
|
|
2015
Q1 | – | Sell |
-197,247
| Closed | -$19.9M | – | 126 |
|
|
2014
Q4 | $19.9M | Buy |
+197,247
| New | +$19.9M | 0.48% | 50 |
|